Human osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitro

Journal of Bone and Mineral Research

Volumn 29, Issue 12, 2014, Pages 2666-2675

  Li, Haiyan ^a   Lu, Yong ^a   Qian, Jianfei ^a   Zheng, Yuhuan ^a   Zhang, Mingjun ^a   Bi, Enguang ^b   He, Jin ^b   Liu, Zhiqiang ^b   Xu, Jingda ^b   Gao, Jerry Y ^b   Yi, Qing ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CD40L; IDO; IFN ; Osteoclasts; Osteoimmunology; T CELLS

Indexed keywords

BLOCKING ANTIBODY; CD40 LIGAND; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; IFNG PROTEIN, HUMAN; INDOLEAMINE 2,3-DIOXYGENASE 1, HUMAN;

ARTICLE; BONE METASTASIS; BYSTANDER EFFECT; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; MULTIPLE MYELOMA; OSTEOCLAST; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; CYTOLOGY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; PHYSIOLOGY;

CD40 LIGAND; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNE TOLERANCE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON-GAMMA; MALE; OSTEOCLASTS; T-LYMPHOCYTES;

EID: 84918515913     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2294     Document Type: Article

References (40)

1. Lorenzo J, Horowitz M, Choi Y. Osteoimmunology: Interactions of the bone and immune system. Endocr Rev. 2008;29(4): 403-40.
2. Lee SH, Kim TS, Choi Y, Lorenzo J. Osteoimmunology: Cytokines and the skeletal system. BMB Rep. 2008;41(7): 495-510.
3. Di Rosa F, Pabst R. The bone marrow: A nest for migratory memory T cells. Trends Immunol. 2005;26(7): 360-6.
4. Feuerer M, Beckhove P, Garbi N, et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med. 2003;9(9): 1151-7.
5. Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008;2(2): 141-50.
6. Li H, Hong S, Qian J, Zheng Y, Yang J, Yi Q. Cross talk between the bone and immune systems: Osteoclasts function as antigenpresenting cells and activate CD4+ and CD8+ T cells. Blood. 2010; 116(2): 210-7.
7. Takayanagi H. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol. 2007; 7(4): 292-304.
8. Arron JR, Choi Y. Bone versus immune system. Nature. 2000; 408(6812): 535-6.
9. Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000;408(6812): 600-5.
10. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 1999;402(6759): 304-9.
11. Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006;203(12): 2673-82.
12. Takayanagi H. New immune connections in osteoclast formation. Ann N Y Acad Sci. 2010;1192: 117-23.
13. Zaiss MM, Axmann R, Zwerina J, et al. Treg cells suppress osteoclast formation: A new link between the immune system and bone. Arthritis Rheum. 2007;56(12): 4104-12.
14. Kiesel JR, Buchwald ZS, Aurora R. Cross-presentation by osteoclasts induces FoxP3 in CD8+ T cells. J Immunol. 2009;182(9): 5477-87.
15. Grassi F, Manferdini C, Cattini L, et al. T cell suppression by osteoclasts in vitro. J Cell Physiol. 2011;226(4): 982-90.
16. Chung DJ, Rossi M, Romano E, et al. Indoleamine 2, 3-dioxygenaseexpressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells. Blood. 2009;114(3): 555-63.
17. Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med. 2010;16(4): 452-9.
18. Kretschmer K, Apostolou I, Jaeckel E, Khazaie K, von Boehmer H. Making regulatory T cells with defined antigen specificity: Role in autoimmunity and cancer. Immunol Rev. 2006;212: 163-9.
19. Zhang J. Yin and yang interplay of IFN-gamma in inflammation and autoimmune disease. J Clin Invest. 2007;117(4): 871-3.
20. Jeong YI, Kim SW, Jung ID, et al. Curcumin suppresses the induction of indoleamine 2, 3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferongamma- stimulated murine dendritic cells. J Biol Chem. 2009;284(6): 3700-8.
21. Kondo A, Yamashita T, Tamura H, et al. Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes. Blood. 2010;116(7): 1124-31.
22. Ridge JP, Di Rosa F, Matzinger P. A conditined dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998;393(6684): 474-8.
23. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 1998;393(6684): 478-80.
24. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393(6684): 480-3.
25. O'Sullivan B, Thomas R. CD40 and dendritic cell function. Crit Rev Immunol. 2003;23(1-2): 83-107.
26. Lob S, Konigsrainer A, Rammensee HG, Opelz G, Terness P. Inhibitors of indoleamine-2, 3-dioxygenase for cancer therapy: Can we see the wood for the trees? Nat Rev Cancer. 2009;9(6): 445-52.
27. Mellor AL, Munn DH. IDO expression by dendritic cells: Tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4(10): 762-74.
28. Munn DH. Blocking IDO activity to enhance anti-tumor immunity. Front Biosci (Elite Ed). 2012;4: 734-45.
29. Zhuang J, Zhang J, Lwin ST, et al. Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells. PLoS One. 2012;7(11): E48871.
30. Sawant A, Deshane J, Jules J, et al. Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer. Cancer Res. 2013;73(2): 672-82.
31. Charles JF, Hsu LY, Niemi EC, Weiss A, Aliprantis AO, Nakamura MC. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest. 2012;122(12): 4592-605.
32. Muller A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, Daubener W. The missing link between indoleamine 2, 3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med. 2009; 13(6): 1125-35.
33. Kim H, Chen L, Lim G, et al. Brain indoleamine 2, 3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest. 2012;122(8): 2940-54.
34. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood. 2004;103(12): 4619-21.
35. Gao Y, Grassi F, Ryan MR, et al. IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest. 2007;117(1): 122-32.
36. Kim JW, Lee MS, Lee CH, et al. Effect of interferon-gamma on the fusion of mononuclear osteoclasts into bone-resorbing osteoclasts. BMB Rep. 2012;45(5): 281-6.
37. Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ. Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunol Rev. 2009;229(1): 152-72.
38. Kollet O, Dar A, Shivtiel S, et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med. 2006;12(6): 657-64.
39. Berner B, Akca D, Jung T, Muller GA, Reuss-Borst MA. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. J Rheumatol. 2000;27(5): 1128-35.
40. Maeshima K, Yamaoka K, Kubo S, et al. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-gamma and interleukin-17 production by human CD4+ T cells. Arthritis Rheum. 2012;64(6): 1790-8.